BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices - Vascular Disease Management

BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices  Vascular Disease Management

FRANKLIN LAKES, N.J., June 20, 2019 — BD (Becton, Dickinson and Company) issued the following statement following the U.S..